Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Clinical trial NCT00006368 · COMPLETED

Trial details

NCT number: NCT00006368
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Breast Cancer Gastrointestinal Carcinoid Tumor Islet Cell Tumor Lung Cancer Lymphoma Melanoma (Skin)Neoplastic Syndrome

Start date: 1998-01-01
Primary completion: 2003-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.